We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes

Larry C. Gilstrap, MD; Robert Christensen, MD; William H. Clewell, MD; Mary E. D'Alton, MD; Ezra C. Davidson Jr, MD; Marilyn B. Escobedo, MD; Dwenda K. Gjerdingen, MD; Jan Goddard-Finegold, MD; Robert L. Goldenberg, MD; David A. Grimes, MD; Thomas N. Hansen, MD; Ralph E. Kauffman, MD; Emmett B. Keeler, PhD; William Oh, MD; Elizabeth J. Susman, PhD, RN; Marlyn G. Vogel, EdD; Mary Ellen Avery, MD; Philip L. Ballard, MD, PhD; Roberta A. Ballard, MD; Patricia Crowley, MRCOG, FRCPI; Thomas Garite, MD; Gary D.V. Hankins, MD; Alan H. Jobe, MD, PhD; Janna G. Koppe, MD, PhD; James E. Maher, MD; Irwin R. Merkatz, MD; Seetha Shankaran, MD; Kit N. Simpson, DrPH; John C. Sinclair, MD; Theodore A. Slotkin, PhD; H. William Taeusch Jr, MD; Linda L. Wright, MD; Duane Alexander, MD; Mary Anne Berberich, PhD; Michael Bracken, PhD; Leslie Cooper, PhD; Larry Culpepper, MD, MPH; Jerry M. Elliott; John H. Ferguson, MD; Frederic Frigoletto, MD; Dorothy Berlin Gail, PhD; William H. Hall; M. Douglas Jones Jr, MD; Barbara Medoff-Cooper, PhD; Gerald B. Merenstein, MD; Judith M. Whalen, MPA; Claude Lenfant, MD; Ada Sue Hinshaw, PhD, RN
JAMA. 1995;273(5):413-418. doi:10.1001/jama.1995.03520290065031.
Text Size: A A A
Published online


Objective.  —To develop a consensus on the use of antenatal corticosteroids for fetal maturation in preterm infants.

Participants.  —A nonfederal, nonadvocate, 16-member consensus panel including representatives from neonatology, obstetrics, family medicine, behavioral medicine, psychology, biostatistics, and the public; 19 experts in neonatology, obstetrics, and pharmacology presented data to the consensus panel and a conference audience of approximately 500.

Evidence.  —An extensive bibliography of references was produced for the consensus panel and the conference audience using a variety of on-line databases including MEDLINE. The consensus panel met several times prior to the conference to review the literature. It also commissioned an updated meta-analysis, a neonatal registry review, and an economic analysis that were presented at the conference. The experts prepared abstracts for distribution at the conference, presented data, and answered questions from the panel and audience. The panel evaluated the strength of the scientific evidence using the grading system developed by the Canadian Task Force on the Periodic Health Examination and adapted by the US Preventive Services Task Force.

Consensus.  —The consensus panel, answering predefined consensus questions, developed their conclusions based on the scientific evidence presented in open forum and the scientific literature.

Consensus Statement.  —The consensus panel composed a draft statement that was read in its entirety at the conference for comment. The panel released a revised statement at the end of the conference and finalized the revisions a few weeks after the conference.

Conclusions.  —Antenatal corticosteroid therapy is indicated for women at risk of premature delivery with few exceptions and will result in a substantial decrease in neonatal morbidity and mortality, as well as substantial savings in health care costs. The use of antenatal corticosteroids for fetal maturation is a rare example of a technology that yields substantial cost savings in addition to improving health.(JAMA. 1995;273:413-418)


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.